. Author manuscript; available in PMC: 2020 Dec 15.

Published in final edited form as: Am J Cardiol. 2019 Sep 26;124(12):1947–1953. doi: 10.1016/j.amjcard.2019.09.016

Table 1.

Baseline Demographics for Patients with IABP Placed for Cardiogenic Shock

	All (N=205)	ADHF-CS (N=132)	AMI-CS (N=73)	p-value
Age (years)	65.0 ± 13.8	61.2 ± 13.0	71.8 ± 12.7	<0.0001
Men	148 (72.2%)	111 (84.1%)	37 (50.7%)	<0.001
Body Surface Area (m²)	1.90 ± 0.24	1.93 ± 0.25	1.85 ± 0.22	0.02
Diabetes Mellitus	82 (40.0%)	44 (33.3%)	38 (52.1%)	0.009
Left Ventricular
Ejection Fraction (percent)	22.2 ± 11.7	18.0 ± 8.9	30.2 ± 12.2	<0.0001
Left Ventricular End
Diastolic Diameter (cm)	6.2 ± 1.5	7.0 ± 1.1	4.8 ± 0.9	<0.0001
Serum Creatinine (mg/dL)	1.83 ± 1.09	1.97 ± 1.06	1.59 ± 1.11	0.02
Serum Lactate (mg/dL)	3.65 ± 3.58	2.54 ± 2.50	4.92 ± 4.21	0.003

ADHF-CS, acute decompensated heart failure – cardiogenic shock; AMI-CS, acute myocardial infarction – cardiogenic shock.